SEOM clinical guidelines for the treatment of antiemetic prophylaxis in cancer patients receiving chemotherapy.
Chemotherapy-induced emesis is one of the most frequent side effects that affect the quality of life of cancer patients undergoing chemotherapy. In recent years, clinical research has allowed us to increase our therapeutic arsenal with new drugs that have increased efficiency in the control of nausea and vomiting associated with chemo. This guide provides and update of the earlier published by our society and represents the continued commitment of SEOM to move forward and improve in the supportive care of cancer patients.
García Gómez
Jesús
J
Servicio de Oncología Médica, Complejo Hospitalario de Orense, Orense, Spain. jesus.garcia.gomez@sergas.es
Pérez López
M Eva
ME
García Mata
Jesús
J
Isla Casado
Dolores
D
D000465:Algorithms; D000932:Antiemetics / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use*; D018890:Chemoprevention / Q000379:methods; D006801:Humans; D008495:Medical Oncology / Q000331:legislation & jurisprudence / Q000379:methods*; D009369:Neoplasms / Q000188:drug therapy*; D012955:Societies, Medical; D013030:Spain; D014839:Vomiting / Q000139:chemically induced / Q000517:prevention & control*
D000932:Antiemetics